Mortality, cardiovascular risk and androgen deprivation therapy for prostate cancer. A systematic review with direct and network meta-analyses of randomized controlled trials and observational studies - Archive ouverte HAL Access content directly
Journal Articles Fundamental & Clinical Pharmacology Year : 2016

Mortality, cardiovascular risk and androgen deprivation therapy for prostate cancer. A systematic review with direct and network meta-analyses of randomized controlled trials and observational studies

Not file

Dates and versions

hal-01310756 , version 1 (03-05-2016)

Identifiers

  • HAL Id : hal-01310756 , version 1

Cite

L. M. Scailteux, Florian Naudet, Q. Alimi, S. Vindendeau, E Oger. Mortality, cardiovascular risk and androgen deprivation therapy for prostate cancer. A systematic review with direct and network meta-analyses of randomized controlled trials and observational studies. Fundamental & Clinical Pharmacology, 2016, 30, pp.7--7. ⟨hal-01310756⟩
38 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More